South Korea stocks combined as central lender retains prices, China producing contracts additional

South Korea stocks combined as central lender retains prices, China producing contracts additional


A Chinese flag flutters on major of the Great Hall of the Folks in advance of the opening ceremony of the Belt and Street Discussion board (BRF), to mark 10th anniversary of the Belt and Street Initiative, in Beijing, China Oct 18, 2023.

Edgar Su | Reuters

South Korea inventory marketplaces were mixed on Thursday following the country’s central lender held lending fees for the seventh straight time, even though China and Hong Kong equities fell as manufacturing activity in China contracted additional.

South Korea’s central bank has held its benchmark plan charge at 3.5%, saying that while inflation in the place has been elevated, its is even now projected to slow down.

Asia-Pacific markets fell as investors assessed economic knowledge from the area.

China’s manufacturing facility exercise shrank for a next straight thirty day period in November, although non-producing activity strike however another new minimal for the calendar year.

South Korea’s industrial output quantities amazed the market, registering a 3.5% drop compared to anticipations of a .5% rise from economists polled by Reuters. The place will also see its central bank announce its level choice currently.

China’s CSI 300 index dipped .1% times just after the open up, while Hong Kong’s Cling Seng index fell .5%.

Japan’s Nikkei 225 slid .34% and prolonged its a few-working day shedding streak, with the Topix also down by .34%.

South Korea’s Kospi was flat, while the compact-cap Kosdaq obtained .55% after the monetary policy selection.

In Australia, the S&P/ASX 200 inched down marginally.

On Wednesday in the U.S., all a few important indexes generally remained in the vicinity of the flat line, even as the U.S. economy grew extra than predicted.

GDP in the third quarter accelerated at a 5.2% annualized tempo, greater than the 5% Dow Jones forecast and previously mentioned the preliminary estimate of 4.9%.

The 30-stock Dow was up .04%, even though the S&P 500 ticked down by .09% and the Nasdaq Composite slipped by .16%.

— CNBC’s Pia Singh and Brian Evans contributed to this report



Supply

PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates
World

PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates

PayPal reported better-than-expected results for the second quarter and raised its full-year guidance for transaction margin dollars and earnings per share. The stock slipped more than 4% following the report. Here’s how the company did compared with Wall Street estimates, based on a survey of analysts by LSEG: Earnings per share: $1.40 adjusted vs. $1.30 expected […]

Read More
Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance
World

Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were […]

Read More
Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal
World

Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal

Shelf of pharmaceutical products. D3sign | Moment | Getty Images Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes […]

Read More